News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Amgen pays $2.2bn for Abgenix

Amgen, the US biotechnology company, is buying Abgenix for $2.2bn (€1.8bn) in the largest M&A deal in the US biotech sector. Morgan Stanley is advising Amgen and Goldman Sachs is adviser to Abgenix.

Sullivan & Cromwell is legal counsel to Amgen and Dewey Ballantine is legal adviser for Abgenix.

WSJ Logo